tiprankstipranks
Trending News
More News >
Ascentage Pharma Group International Unsponsored ADR (AAPG)
NASDAQ:AAPG
US Market
Advertisement

Ascentage Pharma Group International Unsponsored ADR (AAPG) Dividend Date & History

Compare
20 Followers
Ascentage Pharma Group International Unsponsored ADR (AAPG) has no upcoming dividends

Other Large Cap Stocks Paying Dividends

Name
Dividend Yield
Smart Score
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Follow
$4.12 (7.21%)
$96.20B
10.93
+6.76%
3 Buy
2 Hold
1 Sell
Moderate Buy
$1.11 (4.52%)
$173.27B
7.94
+11.43%
11 Buy
5 Hold
0 Sell
Moderate Buy
$0.425 (14.12%)
$386.30M
-0.38
-66.18%
0 Buy
1 Hold
1 Sell
Moderate Sell
$6.7 (2.18%)
$281.22B
35.99
+46.20%
7 Buy
6 Hold
1 Sell
Moderate Buy
$6.76 (4.43%)
$314.05B
21.66
-2.44%
11 Buy
4 Hold
0 Sell
Moderate Buy
$3.945 (3.75%)
$57.47B
10.24
-16.82%
12 Buy
13 Hold
0 Sell
Moderate Buy
$1.305 (7.72%)
$56.81B
12.77
-3.10%
8 Buy
1 Hold
0 Sell
Strong Buy
$1.92 (9.6%)
$14.59B
10.24
-6.24%
8 Buy
2 Hold
0 Sell
Strong Buy
$2.903 (8.67%)
$7.10B
12.02
-5.34%
1 Buy
7 Hold
0 Sell
Hold

FAQ

How much is Ascentage Pharma Group International Unsponsored ADR's dividend?
Ascentage Pharma Group International Unsponsored ADR (AAPG) does not pay a dividend
When is Ascentage Pharma Group International Unsponsored ADR ex-dividend date?
Ascentage Pharma Group International Unsponsored ADR (AAPG) does not pay a dividend.
When is Ascentage Pharma Group International Unsponsored ADR dividend payment date?
Ascentage Pharma Group International Unsponsored ADR (AAPG) does not pay a dividend.
Does Ascentage Pharma Group International Unsponsored ADR have sufficient earnings to cover their dividend?
The Ascentage Pharma Group International Unsponsored ADR has paid a dividend in the last year and may provide dividends in the near future.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis